Development of Nodular Lesions after Dupilumab Therapy in Erythrodermic Mycosis Fungoides with Interleukin-13 Receptor alpha2 Expression

Acta Derm Venereol. 2022 Aug 24:102:adv00766. doi: 10.2340/actadv.v102.2234.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Humans
  • Interleukin-13 Receptor alpha2 Subunit*
  • Mycosis Fungoides* / pathology
  • Sezary Syndrome* / pathology
  • Skin Neoplasms* / pathology

Substances

  • Antibodies, Monoclonal, Humanized
  • Interleukin-13 Receptor alpha2 Subunit
  • dupilumab